T-Cell-Replete HLA-Haploidentical Transplantation Using Post-Transplantation High-Dose Cyclophosphamide in High Risk and Advanced ALL: Feasibility and Early Outcome
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.870
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Elsevier BV